Shifting from reducing MA capitation by an across-the-board coding intensity adjustment factor to Medicare Advantage ...

Private equity (PE) acquisitions of health care providers are often framed as a monolithic intervention, but firms’ strategies for generating returns for investors may vary. In a ...

Consolidation of physician practices, largely driven by health systems, has motivated policy efforts to move care toward lower-price, non–health system settings. At the same time, however, private ...

In a “rapid response” to the changing administration, authors write: “The current moment in American health care and politics presents new challenges but also new opportunities to advance the goals of ...

Given the prevalence of managed care, it’s incumbent upon the industry to ensure that there is a robust supplier pool.

The FDA’s framework for AI regulation, while robust for premarket evaluation, would benefit from more specific mechanisms for continuous monitoring of AI performance in diverse real-world settings.

When manufacturers and public health officials took steps more than two decades ago to remove thimerosal from most pediatric vaccines, their intention was to bolster public confidence. Instead, it ...

Health Affairs' Senior Deputy Editor Rob Lott interviews Paige Nong of the University of Minnesota about her recent paper that evaluates and explores the current use of artificial intelligence and ...

This article is the latest in the Health Affairs Forefront series, Provider Prices in the Commercial Sector, featuring analysis and discussion of physician, hospital, and other health care ...

Health Affairs' Senior Deputy Editor Rob Lott interviews Don Berwick of the Institute for Healthcare Improvement about his paper as part of the Vital Directions for Health and Health Care: Priorities ...